Tevogen signs LOI to explore acquisition of HRK Healthcare
TVGN•Tevogen entered a signed, non-exclusive, non-binding letter of intent to evaluate a potential acquisition of HRK Healthcare. Management cited a potential path to about $100 million in combined annual revenue if the deal is completed with other acquisition initiatives.
1. Potential acquisition
Tevogen said it signed a non-exclusive, non-binding letter of intent to evaluate acquiring HRK Healthcare. The transaction remains subject to due diligence, definitive agreements, required approvals and customary closing conditions. Tevogen said the acquisition could expand healthcare infrastructure capabilities alongside planned services arms Tevogen Bio and Tevogen.AI.
